4th Quarter - Report

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,960,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2016 $1,960,000 Replaced
4th Quarter - Amendment Jan 21, 2016 $1,960,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, charitable IRA rollover within tax extenders legislative proposals, including governance of nonprofit organizations.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
GREGG HAIFLEY —
TATIANA LOWELL-CAMPBELL —
CAROLINE POWERS —
RICHARD WOODRUFF —

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); SENATE; White House Office; Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Labor, Dept of (DOL); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); White House Office

Bills named: S. 1170 (114th), S. 705 (114th), S. 1014 (114th), H.R. 1608 (114th), H.R. 716 (114th), S. 370 (114th), H.R. 2191 (114th), S. 540 (114th), H.R. 2739 (114th), H.R. 644 (114th), H.R. 2846 (114th), S. 1566 (114th), H.R. 3119 (114th)

Medicare/Medicaid MMM

Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues before CMS relating to: Medicare payment for preventive screening; coordinated patient care; care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON New —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
BRYAN HANNON —
KATRINA KAMM —
TATIANA LOWELL-CAMPBELL —
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
BLAKE WINDHAM Intern for Senator John Cornyn
RICHARD WOODRUFF —

Contacted: SENATE; Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS)

Bills named: H.R. 1220 (114th), S. 624 (114th), H.R. 1190 (114th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; S.1558, Department of Defense Appropriations Act; and H.R.2029, Mil-Con Veterans Affairs (Omnibus) Appropriations Act.

Contacted: Natl Institutes of Health (NIH); Labor, Dept of (DOL); Environmental Protection Agency (EPA); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA)

Bills named: H.R. 2029 (114th), S. 1725 (114th), H.R. 6 (114th), S. 1558 (114th), H.R. 3020 (114th), H.R. 2772 (114th), S. 1695 (114th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430,Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to tobacco control related appropriated accounts, including CDC's Office of Smoking & Health in H.R.2029, Omnibus Appropriations legislation.

Contacted: Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); White House Office; Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); Labor, Dept of (DOL)

Bills named: H.R. 3042 (114th), S. 430 (114th), H.R. 2029 (114th), S. 450 (114th), H.R. 478 (114th), S. 1129 (114th), H.R. 1749 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.